IXIARO: payments to doctors
Payments that named IXIARO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $220K
- Providers
- 28
- Transactions
- 104
- Average per transaction
- $2,113
The per-transaction average — $2,113 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 28 providers the average total is $7,849, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Valneva USA, Inc. | $218,717 | 99.5% |
| Valneva Austria GmbH | $1,050 | 0.5% |